Bristol Myers claims Phase 2 success for GPRC5D-directed CAR-T - endpoints.news
Source: endpoints.news ·
Bristol Myers claims Phase 2 success for GPRC5D-directed CAR-T endpoints.newsBMS’ pivotal CAR-T multiple myeloma trial hits primary endpoint Fierce BiotechBristol Myers' blood cancer cell therapy succeeds in mid-stage trial ReutersNext-gen CAR-T from BMS passes pivotal test in quadruple-class exposed myeloma FirstWord PharmaArlo-Cel Meets ORR End Point in BCMA-Pretreated, Quadruple-Class Exposed…